{
    "Trade/Device Name(s)": [
        "C-Reactive Protein (Latex) High Sensitive test system for COBAS Integra instruments",
        "CRP (latex) HS",
        "hsCRP test system"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K053603",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042485",
        "K033908"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD"
    ],
    "Summary Letter Date": "February 9, 2006",
    "Summary Letter Received Date": "December 23, 2005",
    "Submission Date": "December 22, 2005",
    "Regulation Number(s)": [
        "21CFR866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "C-reactive protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "COBAS Integra family of analyzers (Integra 400/700/800)"
    ],
    "Method(s)/Technology(ies)": [
        "Latex particle-enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche C-Reactive Protein (Latex) High Sensitive immunoturbidimetric assay for COBAS Integra analyzers to quantitatively measure CRP in serum and plasma.",
    "Indications for Use Summary": "For in vitro quantitative determination of C-reactive protein (CRP) in human serum and plasma; useful for detecting and evaluating inflammatory disorders, infections, tissue injury, and as an aid in coronary heart disease risk assessment and prognosis in acute coronary syndromes.",
    "fda_folder": "Immunology"
}